Guardant Health (GH) Receivables - Other (2019 - 2021)

Guardant Health has reported Receivables - Other for 3 years, with the latest figure at $2.2 million in Q1 2021.

• Quarterly Receivables - Other fell 75.82% year-over-year to $2.2 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $2.2 million (down 75.82% YoY) and the FY2020 annual result came in at $1.8 million, up 28.57% from the prior year.
• Receivables - Other grew to $2.2 million in Q1 2021 per GH's latest filing, from $1.8 million in the prior quarter.
• Over five years, Receivables - Other peaked at $13.4 million in Q3 2020 and troughed at $1.4 million in Q4 2019.
• A 3-year average of $5.8 million and a median of $5.2 million in 2019 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2020 and 2021: Receivables - Other jumped 135.09% in 2020, then sank 75.82% in 2021.
• Over 3 years, Receivables - Other stood at $1.4 million in 2019, then gained by 28.57% to $1.8 million in 2020, then climbed by 22.22% to $2.2 million in 2021.
• According to Business Quant data, Receivables - Other over the past three periods registered $2.2 million, $1.8 million, and $13.4 million for Q1 2021, Q4 2020, and Q3 2020 respectively.